Aimedis IDO

Aimedis IDO

Created using Figma
Aimedis - an eHealth platform based on blockchain technology, which has been developed since 2017 and released in the current version 2020 for web, iOS and Android. Aimedis combineseHealth applications such as health records, video chat with doctors, appointments, prescriptions, second opinions, wearables, emergency records and much more along with medical social media platform, eLearning, eTeaching and education, a unique medical and scientific-pharmaceutical NFT marketplace, while displaying all relevant operations in a private blockchain, visible and transparent for the patient. Aimedis builds the world’s first medical metaverse and opens the world’s first virtual hospital chain in the metaverse while offering space to other hospitals, companies, universities and people.
  • 시장
    가격
    24H 권
    24H (가격)
    24H (부피)
  • BitMart
    AIMX/USDT 1 년 전
    $ 0.0201
    $ 223.606 K
    -
    -
  • ProBit Global
    AIMX/USDT 1 년 전
    $ 0.0071
    $ 18.141 K
    -
    -
To be announced
토큰 세부 정보
증권 시세 표시기
AIMX
기업 세부 정보
등록 된 국가
Netherlands
추가 세부 사항
MVP / 프로토 타입
카테고리
플랫폼, 건강

약 Aimedis IDO

Aimedis combines all relevant eHealth applications such as health records, video chat with doctors, appointments, prescriptions, second opinions, wearables, medical social media communication, eLearning, the world's first medical and scientific-pharmaceutical NFT marketplace, while displaying all relevant operations in a private blockchain, visible and transparent for the patient. The Aimedis token, which is tailored to the platform, is much more than just utility and payment tokens, it also offers staking, governance, DeFi (the first medical DeFi token) and the next hot trend in the field of cryptocurrencies, social token functionalities . Aimedis has already generated more than 1.4M USD in 2020 and is active on several continents.

Aimedis combines your health data, onliner prescriptions, video consultation with doctors and psychologists, information, medical hardware, your smart devices, and more on a single platform on your PC, your smartphone or your tablet, anytime, worldwide and in multiple languages.

Blockchain smart contracts smart graphs artificial intelligence highest security standards payments cryptocurrencies ICD ATC HL7 FHIR HIPPA IHE DICOM.

Soon Aimedis will offer much more including AIMSocial - the interactive patient platform that is secured and supported by a blockchain and help patients to support each other on a new level.

 

풍모

• Digital therapy & healthcare services
• B2B business – medical & scientific data NFT marketplace
• Hospital & rehab information system
• Advertising platform for healthcare providers & pharma
• Data platform for pharmaceutical and healthcare research
• IoT & tracker integration
• Insurance program hubs
• Online pharmacy and shop
• A steadily growing medical ecosystem
• Incentivized growing educational and social medical network
• eLearning & eTeaching

% name % 로드맵

  • Q1 2022

  • Public launch of Aimedis DataXChange NFT marketplace including new trials

    First version of Aimedis Avalon including Aimedis Virtual Campus & Aimedis Museum of Virtual Medical Art V1 release in Unreal Engine 5 and Aimedis NFTs
  • Q2 2022

  • Aimedis – Alpha Hospital opening

    Public release of Aimedis Virtual Hospital and Rehab
  • Q3 2022

  • Aimedis Pharmacy & IoT incl. implementation with Aimedis Health
  • Q4 2022

  • Aimedis Blockchain: AIMChain V4 release including further decentralization

Aimedis IDO 팀

검증 됨 0%

주의. 확인되지 않은 회원은 실제로 팀원이 아닌 위험이 있습니다.

Dr. Henry Adapon
MD - President
확인되지 않음
Benny Adapon
Manager of Strategic Planning
확인되지 않음
Daniella B. Sevilla
Director of Digital Marketing
확인되지 않음
Matthew Rutter
COO
확인되지 않음
Michael J. Kaldasch
CEO, MD & founder
확인되지 않음
Ben O. El Idrissi
COO, MD & founder
확인되지 않음
Roxana Nasoi
M.Sc. CCO & Partnerships
확인되지 않음

2 ICO

$3 288 740

Miguel Sanchez De Pe...
CFO
확인되지 않음
Jack Yehoshua Westov...
CBO
확인되지 않음
Benjamin C. Sevilla
Chairman
확인되지 않음

Aimedis IDO 최근 뉴스

  • 정보 업데이트에는 시간차가있을 수 있으므로 각 ICO 프로젝트에 대한 정확한 정보는 공식 웹 사이트 또는 기타 커뮤니케이션 채널을 통해 확인해야합니다.
  • 이 정보는 ICO 기금 투자에 대한 제안이나 조언이 아닙니다. 관련 정보를 철저히 조사하고 ICO 참여를 결정하십시오.
  • 이 콘텐츠에 대해 수정해야 할 문제 또는 문제가 있다고 생각되거나 자신의 ICO 프로젝트를 제출하고자 할 경우 이메일을 보내주십시오. a>
면책 조항 및 위험 경고를 읽으십시오. 면책 조항 및 위험 경고 표시.